Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:SESN

Sesen Bio (SESN) Stock Price, News & Analysis

Sesen Bio logo

About Sesen Bio Stock (NASDAQ:SESN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.63
$12.99
52-Week Range
N/A
Volume
93,330 shs
Average Volume
1.07 million shs
Market Capitalization
$2.56 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sesen Bio, Inc. engages in designing, engineering, and developing targeted protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA.

Receive SESN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sesen Bio and its competitors with MarketBeat's FREE daily newsletter.

SESN Stock News Headlines

Trey Mewes
Sesen Bio (NASDAQ: SESN)
Buy this Stock before Trump Takes Office!
We're issuing an urgent "buy alert" on a little-known "AI company" set to SOAR under this new administration. And it's not just because it hit a critical "buy now" price.
See More Headlines

SESN Stock Analysis - Frequently Asked Questions

Sesen Bio, Inc. (NASDAQ:SESN) announced its quarterly earnings data on Sunday, November, 7th. The company reported $7.20 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($1.40) by $8.60.

Shares of Sesen Bio reverse split before market open on Wednesday, March 8th 2023. The 1-20 reverse split was announced on Wednesday, March 8th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, March 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sesen Bio investors own include Predictive Oncology (POAI), Ford Motor (F), Zomedica (ZOM), NIO (NIO), Bank of America (BAC), Wells Fargo & Company (WFC) and OPKO Health (OPK).

Company Calendar

Last Earnings
11/07/2021
Today
1/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SESN
Employees
35
Year Founded
N/A

Profitability

Net Income
$-19,880,000.00
Pretax Margin
-59.40%

Debt

Sales & Book Value

Annual Sales
$40 million
Book Value
$0.78 per share

Miscellaneous

Free Float
196,980,000
Market Cap
$2.56 billion
Optionable
Optionable
Beta
0.83
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

This page (NASDAQ:SESN) was last updated on 1/6/2025 by MarketBeat.com Staff
From Our Partners